Developing a Burmese version of the SF-36 questionnaire for stroke survivors
Translation, Cross-cultural Adaptation, Reliability, Validity and Responsiveness of Short Form 36 (SF-36) Questionnaire in Stroke Survivors
This study is trying to create a Burmese version of a health questionnaire for stroke survivors in Myanmar to see how well it works for understanding their health and experiences.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 125 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Khon Kaen University Academic / other |
| Locations | 1 site (Yangon) |
| Trial ID | NCT06164145 on ClinicalTrials.gov |
What this trial studies
This observational study aims to translate and culturally adapt the Short Form 36 (SF-36) questionnaire for use among stroke survivors in Myanmar. It will assess the content validity, convergent validity, divergent validity, and reliability of the Burmese version of the SF-36. Additionally, the study will evaluate the responsiveness of this adapted questionnaire to detect meaningful changes over time in stroke survivors' health status. Participants will be interviewed by the research team to gather data on their experiences and satisfaction.
Who should consider this trial
Good fit: Ideal candidates for this study are Burmese-speaking stroke survivors aged 18 and above who have experienced hemiplegia for at least one month.
Not a fit: Patients with other neurological diseases, recurrent strokes, or those unable to understand the Burmese language may not benefit from this study.
Why it matters
Potential benefit: If successful, this study could provide a reliable and valid tool for assessing health-related quality of life in Burmese-speaking stroke survivors.
How similar studies have performed: While the adaptation of health questionnaires has been successful in other contexts, this specific adaptation for the Burmese-speaking stroke population is novel and untested.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Age 18 years and above (Coppers et al., 2021; Soto-Vidal et al., 2021; Wayessa et al., 2023) 2. Hemiplegia induced by both ischemic and hemorrhagic stroke at least 1 month duration (Wayessa et al., 2023; Vincent-Onabajo, Owolabi \& Hamzat, 2014) 3. Ability to understand the study and respond to questions (on the Mini- Mental State Examination \> 23) (Wongchaisuwan et al., 2005; Muangpaisan et al., 2015) 4. Stable medical conditions Exclusion Criteria: 1. Other neurological diseases such as Parkinson's disease, dementia, Alzheimer's disease, peripheral neuropathy according to medical history and record 2. Recurrent stroke 3. Participants with dysphasia, intellectual impairments, traumatic head injury, and psychiatric diseases (Wayessa et al., 2023) 3) Participants who cannot understand Burmese language
Where this trial is running
Yangon
- Yangon General Hospital — Yangon, Myanmar (Recruiting)
Study contacts
- Principal investigator: Myitzu Khin Khin, Master — Khon Kaen University
- Study coordinator: Myitzu Khin Khin, Master
- Email: myitzu.k@kkumail.com
- Phone: +959254219894
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.